Strategic partnerships Active Motif’s recent distribution partnership with Arima Genomics and exclusive rights to Hi-C kits present a clear channel for cross-selling epigenomics tools and services to Arima’s cancer diagnostics network, enabling joint go-to-market opportunities.

Multiomics platform The company emphasizes a multiomics approach linking epigenomics to genomics, transcriptomics and proteomics, which creates upsell potential for integrated data analysis platforms and end-to-end service pipelines for translational research and drug discovery.

Expansion through acquisitions Past acquisitions such as SwitchGear Genomics and AmaryllisNucleics indicate a growth strategy to broaden capabilities in RNA sequencing and custom assays, suggesting sales opportunities for complementary reagents, kits, and validation services.

Broad customer reach With a mid-sized employee base and revenue in the tens of millions, Active Motif serves research labs and translational teams globally, signaling demand for scalable epigenetic tools, high-quality antibodies, validated enzymes, and flexible service options.

Digital & technical readiness Active Motif’s tech stack and partnerships with cloud and analytics platforms imply readiness for data-heavy workflows; there is potential to offer advanced bioinformatics support, cloud-based data analysis, and consulting services to accelerate product adoption.